surmount-1 trial tirzepatide obesity without diabetes proves to be more effective than semaglutide- Results of Surmount 5 Effect of tirzepatide in SURMOUNT-1

This could make the medication more accessible to patients

& Rofstad, E

Many users are simply marveling at the vividness and weirdness of their dreams

What we aim to avoid from the start: Over-escalating dose when symptoms are telling you to slow down Scale-only success that hides muscle loss and nutritional under-fueling Treating side effects like a rite of passage instead of a clinical signal Starting medication without a maintenance strategy (where most regain happens) Myth vs Fact: the misconceptions that cause the most trouble Myth 1: If Im not losing fast, the dose is too low. Fact: Faster is not always better